In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, ATAI Life Sciences N.V’s stock clocked out at $2.32, up 0.43% from its previous closing price of $2.31. In other words, the price has increased by $0.43 from its previous closing price. On the day, 1.8 million shares were traded.
Ratios:
To gain a deeper understanding of ATAI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.07 and its Current Ratio is at 4.07. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 18, 2024, Reiterated its Buy rating but revised its target price to $10 from $15 previously.
On April 03, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $6.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.Loop Capital initiated its Buy rating on November 01, 2022, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 21 ’25 when Kirpekar Sahil sold 48,563 shares for $1.35 per share. The transaction valued at 65,560 led to the insider holds 115,636 shares of the business.
Craig Kevin James sold 11,563 shares of ATAI for $15,610 on Mar 21 ’25. The Chief Medical Officer now owns 8,437 shares after completing the transaction at $1.35 per share. On Mar 21 ’25, another insider, Rao Srinivas, who serves as the insider of the company, sold 75,418 shares for $1.35 each. As a result, the insider received 101,814 and left with 212,942 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1408.43 while its Price-to-Book (P/B) ratio in mrq is 3.05.
Stock Price History:
Over the past 52 weeks, ATAI has reached a high of $2.57, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 51.53%, while the 200-Day Moving Average is calculated to be 58.43%.
Shares Statistics:
A total of 199.78M shares are outstanding, with a floating share count of 134.40M. Insiders hold about 32.91% of the company’s shares, while institutions hold 9.95% stake in the company.
